Suppr超能文献

2007年至2018年间瑞典西部乳腺癌患者先前诊断出的多种原发性恶性肿瘤。

Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018.

作者信息

Nyqvist Jenny, Parris Toshima Z, Helou Khalil, Sarenmalm Elisabeth Kenne, Einbeigi Zakaria, Karlsson Per, Nasic Salmir, Kovács Anikó

机构信息

Department of Surgery, Skaraborgs Hospital, Lidköping, Sweden.

Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

出版信息

Breast Cancer Res Treat. 2020 Nov;184(1):221-228. doi: 10.1007/s10549-020-05822-z. Epub 2020 Aug 1.

Abstract

PURPOSE

Multiple primary malignancies (MPMs) caused by breast cancer treatment are well described, but only few studies to date describe which other previous primary malignancies (OPPMs) occur before breast cancer. The purpose of the present study was to evaluate the prevalence of OPPMs in patients with breast cancer between 2007 and 2018 in Western Sweden.

METHODS

Patient selection was performed using both pathology reports at Sahlgrenska University Hospital (Sweden) and the Swedish Cancer Registry. All newly diagnosed breast cancer patients were screened for presence of OPPM.

RESULTS

In total, 8031 breast cancer patients were diagnosed at Sahlgrenska University Hospital between 2007 and 2018. The prevalence of breast cancer patients with OPPMs (n = 414) increased from on average 2.6% to 8.2% during this 12-year period and ranged from 17 to 59 patients annually. The most striking increase in prevalence was found among the gynecological tumors (endometrium and ovarian adenocarcinomas), malignant melanomas and gastrointestinal malignancies. These findings were validated using data of the Swedish Cancer Registry.

CONCLUSIONS

The overall survival rates for cancer patients have improved tremendously during the past 40 years, in part due to individually tailored therapies and screening programs. Our study revealed an increasing trend of OPPMs in breast cancer patients.

摘要

目的

乳腺癌治疗导致的多原发性恶性肿瘤(MPMs)已有充分描述,但迄今为止只有少数研究描述了在乳腺癌之前发生的其他既往原发性恶性肿瘤(OPPMs)。本研究的目的是评估2007年至2018年瑞典西部乳腺癌患者中OPPMs的患病率。

方法

使用瑞典哥德堡大学萨赫格伦斯卡大学医院的病理报告和瑞典癌症登记处进行患者选择。对所有新诊断的乳腺癌患者进行OPPMs筛查。

结果

2007年至2018年期间,萨赫格伦斯卡大学医院共诊断出8031例乳腺癌患者。在此12年期间,患有OPPMs的乳腺癌患者患病率(n = 414)从平均2.6%增加到8.2%,每年范围为17至59例患者。在妇科肿瘤(子宫内膜癌和卵巢腺癌)、恶性黑色素瘤和胃肠道恶性肿瘤中发现患病率增加最为显著。这些发现使用瑞典癌症登记处的数据进行了验证。

结论

在过去40年中,癌症患者的总体生存率有了巨大提高,部分原因是个体化定制的治疗方法和筛查计划。我们的研究揭示了乳腺癌患者中OPPMs呈上升趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07a6/7568709/ea9235238c8d/10549_2020_5822_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验